Sulfasalazine and Red cell distribution width increased - a phase IV clinical study of FDA data
Summary:
Red cell distribution width increased is reported as a side effect among people who take Sulfasalazine (sulfasalazine), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Actemra, and have Juvenile rheumatoid arthritis.
The phase IV clinical study analyzes which people have Red cell distribution width increased when taking Sulfasalazine. It is created by eHealthMe based on reports of 95,646 people who have side effects when taking Sulfasalazine from the FDA, and is updated regularly.
What is Sulfasalazine?
Sulfasalazine has active ingredients of sulfasalazine. It is often used in rheumatoid arthritis. eHealthMe is studying from 96,787 Sulfasalazine users. Check the latest studies of Sulfasalazine.
What is Red cell distribution width increased?
Red cell distribution width increased is found to be associated with 604 drugs and 656 conditions by eHealthMe. Check the latest studies of Red cell distribution width increased.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
95,646 people reported to have side effects when taking Sulfasalazine.
Among them, 155 people (0.16%) have Red cell distribution width increased.
Among these 155 people:
How long have people been on Sulfasalazine when they have Red cell distribution width increased? *
What is the gender of people who have Red cell distribution width increased when taking Sulfasalazine? *
What is the age of people who have Red cell distribution width increased when taking Sulfasalazine? *
What are other drugs people take besides Sulfasalazine? *
What are other side effects people have besides Red cell distribution width increased? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Sulfasalazine and have Red cell distribution width increased?
- Check whether Red cell distribution width increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Sulfasalazine:
- Sulfasalazine (96,787 reports)
Red cell distribution width increased treatments and more:
- Red cell distribution width increased (5,525 reports)
How severe was Red cell distribution width increased and when was it recovered:
Expand to all the drugs that have ingredients of sulfasalazine:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Sulfasalazine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Red cell distribution width increased:
- Red cell distribution width increased (604 drugs)
Browse all the conditions that are associated with Red cell distribution width increased:
- Red cell distribution width increased (656 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on sulfasalazine (the active ingredients of Sulfasalazine) and Sulfasalazine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Finasteride and Gazyva - now
- Sudafed and Zofran drug interactions for men aged 20-29 - 7 seconds ago
- Tramadol and Misoprostol drug interactions for men aged 60+ - 9 seconds ago
- Could Folic Acid cause Oral Herpes? - 15 seconds ago
- Could Tacrolimus cause Hyperkeratosis? - 16 seconds ago
- Drug interactions of Tizanidine Hydrochloride and Furosemide - 18 seconds ago
- Could Tricor cause Joint Stiffness? - 25 seconds ago
- Drug interactions of Temazepam and Voriconazole - 26 seconds ago
- Akineton and Aggression for Men aged 20-29 - 31 seconds ago
- Aplasia Pure Red Cell and drugs of ingredients of amoxicillin - 33 seconds ago